Venture Capital Integrative Research Investment Banking About Us WHAT WE DO We use our integrative research process to uncover and leverage the best opportunities in emerging high-growth segments in technology and healthcare for the benefit of the investors and growth companies we serve, as well as our broader society and environment. Integrative research draws heavily on our relationships with companies and unifies naturally divergent perspectives, capabilities, skill sets, and relationships, yielding a deep, comprehensive understanding of each segment's near-term and long-term potential. Technology / SaaS Healthcare Environmental Technology VENTURE CAPITAL First Analysis is a leading venture capital investor, having invested more than $800 million over four decades. Leveraging our integrative research process, we partner with strong teams leading rapid-growth companies to build industry leaders in the targeted sectors where we are acknowledged experts and where success benefits not only our investors, but also our broader society and environment. Learn more INTEGRATIVE RESEARCH Integrative research means our extensive company research informs every thesis and perspective. The result is deep industry knowledge, expertise, and trend insights that yield valuable results for our clients and partners. Learn more INVESTMENT BANKING Our investment bankers have a wealth of industry knowledge, contacts, and execution expertise to drive strategic transactions with uncompromised loyalty to our clients. Learn more NEWS & INSIGHTS See more First Analysis invests in Lender Price, a leader in lending technology First Analysis, a leading venture capital investor, has made a new investment in Lender Price. Lender Price’s cloud-based solutions help banks, mortgage bankers and mortgage brokers increase volumes and profitability, benefit from workflow efficiencies and improve their market competitiveness. The investment, led by longtime First Analysis partner Argentum Group, will further accelerate Lender Price’s rapid growth by supporting product development, sales and marketing and customer service capabi October 15, 2021 First Analysis acted as the exclusive financial advisor to Selerix Systems for its investment by NexPhase Capital First Analysis acted as the exclusive financial advisor to Selerix in securing an investment from NexPhase Capital. Selerix produces software used by employers, brokers and carriers to simplify benefits administration, employee engagement and Affordable Care Act (ACA) reporting. The terms of the transaction were not disclosed. August 26, 2021 First Analysis acted as the exclusive financial advisor to Healthify in its sale to WellSky® First Analysis acted as the exclusive financial advisor to Healthify in its sale to WellSky, a leading health and community care technology company. Healthify improves the health of communities by connecting healthcare organizations with social service organizations to address the social determinants of health (SDoH). Healthify's past investors include SV Health Investors, Sandbox Ventures, Activate Venture Partners, Primary Venture Partners and Acumen. The terms of the transaction were not disc August 03, 2021 Venture Capital Portfolio Companies Submit a Business Plan Venture Capital News Responsible Investment Integrative Research Healthcare Technology / SAAS Investment Banking What We Do Transactions Investment Banking News About Us First Analysis Team First Analysis News Contact Us Careers Important Legal Information Business Continuity Plan Privacy Notice FINRA’s BrokerCheck ©2021 by First Analysis Corporation. One South Wacker Drive · Suite 3900 · Chicago, IL 60606 · 312-258-1400